Total trials
67
Active
25
Phase 3
2
Total enrollment
20,061
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ropivacaine and dexamethasone injection solution | — | — | — | — | — | 1 | |
| Sodium Chloride 0.9% Injection Solution | — | — | — | — | — | 1 |
Next readouts
- 2026-09-04
Top conditions
- Prostate Cancer2
- Quality of Life2
- Endometriosis2
- Cataract2
- Bariatric Surgery Candidate2
- Breast Cancer2
- Obesity2
- Tooth Avulsion1
Frequently asked questions about Elsan
- How many clinical trials does Elsan have on ClinicalTrials.gov?
- Elsan is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 25 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Elsan's trials are in Phase 3?
- 2 of Elsan's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Elsan focus on?
- Elsan's most-studied conditions on ClinicalTrials.gov are Prostate Cancer, Quality of Life, Endometriosis, Cataract, Bariatric Surgery Candidate.
- When are Elsan's next clinical trial readouts?
- Elsan has 1 upcoming primary-completion readout tracked here; the soonest is “Anesthetic Block of the Erector Muscles of the Lumbar Spine to Relieve Acute Lumbar Pain: Pilot Study”, expected around 2026-09-04.